ASTEC LIFESCIENCES LIMITED - 533138 - Notice To Shareholders For Transfer Of Equity Shares And Dividend To Investor Education And Protection Fund (IEPF)
Kindly find enclosed the notice to the Shareholders of the Company for transfer of Equity Shares and Dividend to Investor Education and Protection Fund (IEPF). ASTEC LIFESCIENCES LIMITED - 533138 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Kindly find enclosed the intimation of allotment of Equity Shares of the Company under Employees Stock Option Plan, 2012 (ESOP). ASTEC LIFESCIENCES LIMITED - 533138 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for ICICI Prudential Mutual Fund ASTEC LIFESCIENCES LIMITED - 533138 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Kindly find enclosed the newspaper publication. ASTEC LIFESCIENCES LIMITED - 533138 - Intimation For Change In Senior Management Personnel.
Kindly find enclosed the change in senior management Personnel. Q4FY24 Quarterly & FY24 Annual Result Announced for Astec Lifesciences Ltd.
Agrochemicals company Astec Lifesciences announced Q4FY24 & FY24 results: Q4FY24 Financial Highlights: The Company reported consolidated total income of Rs 155.8 crore in Q4FY24 as compared to Rs 129.5 crore in Q4FY23 The Company reported consolidated EBITDA of Rs 14.8 crore in Q4FY24 as compared to Rs8.0 crore in the same period last year FY24 Financial Highlights: The Company reported consolidated total income of Rs 463.8 crore in FY24 as compared to Rs 641.2 crore in FY23 The Company reported consolidated EBITDA loss of Rs 0.3 crore in FY24 as compared to profit of Rs 89.3 crore in the same period last year Commenting on the performance, N B Godrej, Chairman, Astec LifeSciences Limited, said:" Astec witnessed a slowdown in its enterprise products portfolio in both domestic as well as global markets. Contract manufacturing (CMO) along with new products development performance, however, was in line with our expectations. Revenues from this segment grew 57% in the quarter due to new product development. During the quarter, Astec maintained a steady focus on new product development along with strategic commitment to long-term R&D; projects." Result PDF ASTEC LIFESCIENCES LIMITED - 533138 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Kindly find enclosed the Press Release of the Financial Results for the Quarter and Financial Year ended March 31, 2024. ASTEC LIFESCIENCES LIMITED - 533138 - Announcement under Regulation 30 (LODR)-Change in Directorate
Please find enclosed intimation of cessation of Directorship of Mr. Vijay K. Khot, Independent Director of the Company, with effect from 2nd May, 2024. ASTEC LIFESCIENCES LIMITED - 533138 - Announcement under Regulation 30 (LODR)-Cessation
Please find enclosed the intimation of cessation of Directorship of Mr. Vijay K. Khot, Independent Director of the Company, with effect from the closure of business hours on 2nd May, 2024. ASTEC LIFESCIENCES LIMITED - 533138 - 30Th Annual General Meeting
The 30th (Thirtieth) Annual General Meeting of the Company will be held on Monday, 29th July, 2024, at 4.00 p.m. (IST) by Video Conference / Other Audio Visual Mode.